Skip to main content
SpringerLink
Log in

Over-the-Counter (OTC) Drugs and Some Prescription Drugs

  • Chapter
Drug and Alcohol Abuse

  • 2256 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Berardi, R. R., DeSimone, II, E. M., Newton, E. D., Oszko, M. A., Popovich, N. G., Rollins, C. J., Shimp, L. A., & Tietze, K. J. Handbook of Non-Prescription Drugs (14th ed.). Washington, DC: American Pharmaceutical Association, 2004.

    Google Scholar 

  2. Pies, R. Adverse neuropsychiatric reactions to herbal and over-the-counter “antidepressants”. Journal of Clinical Psychiatry 61:815–820, 2000.

    PubMed  Google Scholar 

  3. Carlos Poston, II, L.W. S., Fan, L., Rakowski, R., Ericsson, M., Bunn, C. C., & Foreyt, J. P. Legal and regulatory perspectives on dietary supplements and foods. Drugs and Society 15:65–85, 2000.

    Article  Google Scholar 

  4. Beaubrun, G., & Gray, G. E. A review of herbal medicines for psychiatric disorders. Psychiatric Services 51:1130–1134, 2000.

    Article  PubMed  Google Scholar 

  5. Pyevich, D., & Bogenschutz, M. P. Herbal diuretics and lithium toxicity. American Journal of Psychiatry 158:1329, 2001.

    Article  PubMed  Google Scholar 

  6. Nemeroff, C. B., & Putnam, J. S. Antihistamines. In B. J. Sadock & V. A. Sadock (Eds.), Comprehensive Textbook of Psychiatry (8th ed.). Baltimore, MD: Lippincott, Williams & Wilkins, 2004, pp. 2772–2774.

    Google Scholar 

  7. Brown, N. J., & Roberts, L. J. Histamine, brodylsinin, and their antagonists. In J. G. Hardman, L. E. Limbird, & A. G. Gilman (Eds.), The Pharmacological Basis of Therapeutics, (10th ed.). New York: McGraw-Hill Medical Publishers, 2001, pp. 645–667.

    Google Scholar 

  8. Cox, D., Ahmed, Z., & McBride, A. J. Diphenhydramine dependence. Addiction 96:516–517, 2001.

    Article  PubMed  Google Scholar 

  9. Vuurman, E. F., Rikken, G. H., Muntjewerff, N. D., DeHalleux, F., & Ramaekers, J. G. Effects of desloratadine, diphenhydramine, and placebo on driving performance and psychomotor performance measurements. European Journal of Clinical Pharmacology 60:307–313, 2004.

    Article  PubMed  Google Scholar 

  10. Halpert, A. G., Olmstead, M. C., & Beninger, R. J. Mechanisms and abuse liability of the anti-histamine dimenhydrinate. Neuroscience Biobehavioral Review 26:61–67, 2002.

    Article  Google Scholar 

  11. Wilken, J. A., Kane, R. L., Ellis, A. K., Rafeiro, E., Briscoe, M. P., Sullivan, C. L., & Day, J. H. A comparison of the effect of diphenhydramine and desloratadine on vigilance and cognitive function during treatment of ragweed-induced allergic rhinitis. Annals of Allergy, Asthma & Immunology 91:375–385, 2003.

    Article  Google Scholar 

  12. Jun, J. H., Thorndike, E. B., & Schindler, C. W. Abuse liability and stimulant properties of dextromethorphan and diphenhydramine combinations in rats. Psychopharmacology 172:277–282, 2004.

    Article  PubMed  Google Scholar 

  13. Kirages, T. J., Sule, H. P., & Mycyk, M. B. Severe manifestations of coricidin intoxication. American Journal of Emergency Medicine 21:473–475, 2003.

    Article  PubMed  Google Scholar 

  14. Baker, S. D., & Borys, D. J. A possible trend suggesting increased abuse from Coricidin exposures reported to the Texas Poison Network: Comparing 1998 to 1999. Veterinary and Human Toxicology 44:169–171, 2002.

    PubMed  Google Scholar 

  15. Ma, O. J. Anticholinergic toxicity. In O. J. Ma & D. M. Cline (Eds.), Emergency Medicine Manual (6th ed.). New York: McGraw-Hill Medical Publishers, 2004, pp. 476–478.

    Google Scholar 

  16. Coco, T. J., & Klasner, A. E. Drug-induced rhabdomyolysis. Current Opinion in Pediatrics 16:206–210, 2004.

    Article  PubMed  Google Scholar 

  17. Hoffman, B. B. Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In J. G. Hardman, L. E. Limbird, & A. G. Gilman (Eds.), The Pharmacological Basis of Therapeutics (10th ed.). New York: McGraw-Hill Medical Publishers, 2001, pp. 215–268.

    Google Scholar 

  18. Gauvin, D. V., Vanecek, S. A., Baird, T. J., Vallett, M., Briscoe, R. J., Carl, K. L., Holloway, F. A., & Sannerud, C. A. The stimulus properties of two common over-the-counter drug mixtures: Dextromethorphan + ephedrine and dextromethorphan + diphenhydramine. Journal of Psychopharmacology 12:84–92, 1998.

    PubMed  Google Scholar 

  19. Roberge, R. J., Hirani, K. H., Rowland, P. L., III, Berkeley, R., & Krenzelok, E. P. Dextromethorphan-and pseudophedrine-induced agitated psychosis and ataxia: Case report. Journal of Emergency Medicine 17:285–288, 1999.

    Article  PubMed  Google Scholar 

  20. Mattoo, S. K., Basu, D., Sharma, A., Balaji, M., & Malhotra, A. Abuse of codeine-containing cough syrups: A report from India. Addiction 92:1793–1787, 1997.

    Article  Google Scholar 

  21. Gutstein, H. B., & Alsil, H. Opioid analgesics. In J. G. Hardman, L. E. Limbird, & A. G. Gilman (Eds.), The Pharmacological Basis of Therapeutics, (10th ed.). New York: McGraw-Hill Medical Publishers, 2001, pp. 569–619.

    Google Scholar 

  22. Bisaga, A., Gianelli, P., & Popik, P. Opiate withdrawal with dextromethorphan. American Journal of Psychiatry 154:584, 1997.

    PubMed  Google Scholar 

  23. Roberts, L. J., & Morrow, J. D. Analgesic-antipyretic, and anti-inflammatory agents and drugs employed in treating gout. In J. G. Hardman, L. E. Limbird, & A. G. Gilman (Eds.), The Pharmacological Basis of Therapeutics (10th ed.). New York: McGraw-Hill Medical Publishers, 2001, pp. 687–731.

    Google Scholar 

  24. Warner, D. C., Schnepf, G., Barrett, M. S., Dian, D., & Swigonski, N. L. Prevalence, attitudes, and behaviors related to the use of nonsteroidal anti-inflammatory drugs (NSAIDs) in student athletes. Journal of Adolescent Health 30:150–153, 2002.

    Article  PubMed  Google Scholar 

  25. Lo, A., Shalansky, S., Leung, M., Hollander, Y., & Raboud, J. Patient characteristics associated with nonprescription drug use in intentional overdose. Canadian Journal of Psychiatry 48:232–236, 2003.

    Google Scholar 

  26. Mausner, K. L. Analgesics. In O. J. Ma & D. M. Cline (Eds.), Emergency Medicine Manual (6th ed.). New York: McGraw-Hill Medical Publishers, 2004, pp. 505–511.

    Google Scholar 

  27. Gyamlani, G. G., & Parikh, C. R. Acetaminophen toxicity: Suicidal vs. accidental. Critical Care 6:155–159, 2002.

    Article  PubMed  Google Scholar 

  28. Clunie, M., Crone, L. A., Klassen, L., & Yip, R. Psychiatric side effects of indomethacin in parturients. Canadian Journal of Anaesthesia 50:586–568, 2003.

    PubMed  Google Scholar 

  29. Browning, C. H. Nonsteroidal anti-inflammatory drugs and severe psychiatric side effects. International Journal of Psychiatry in Medicine 26:25–34, 1996.

    PubMed  Google Scholar 

  30. Zimmerman, J. J., & Maddrey, W. C. Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: Analysis of instances of therapeutic misadventure. Hepatology 22:767–773, 1995.

    Article  PubMed  Google Scholar 

  31. Chetty, R., Baoku, Y., Mildner, R., Banerjee, A., Vallance, D., Haddon, A., & Labib, M. Severe hypokalaemia and weakness due to Nurofen misuse. Annals of Clinical Biochemistry 40:422–423, 2003.

    Article  PubMed  Google Scholar 

  32. Jafri, S., & Pasricha, P. J. Agents used for diarrhea, constipation, and inflammatory bowel disease. In J. G. Hardman, L. E. Limbird, & A. G. Gilman (Eds.), The Pharmacological Basis of Therapeutics (10th ed.). New York: McGraw-Hill Medical Publishers, 2001, pp. 1037–1058.

    Google Scholar 

  33. Berardi, R. R. (Ed.). Gastrointestinal disorders. In R. R. Berardi, E. M. DeSimone II, G. D. Newton, et al. (Eds.), Handbook of Nonprescription Drugs (14th ed.). Washington, DC: American Pharmaceutical Association, 2004.

    Google Scholar 

  34. Korzets, Z., Hasdan, G., Podjarny, E., & Bernheim, J. Excessive fluid gain in a chronic laxative abuser: “Pseudo-idiopathic” oedema. Nephrology, Dialysis, Transplantation 17:161–162, 2002.

    Article  PubMed  Google Scholar 

  35. Duncan, A., & Forrest, J. A. Surreptitious abuse of magnesium laxatives as a cause of chronic diarrhea. European Journal of Gastroenterology and Hepatology 13:599–601, 2001.

    Article  PubMed  Google Scholar 

  36. Wald, A. Is chronic use of stimulant laxatives harmful to the colon? Journal of Clinical Gastroenterology 36:386–389, 2003.

    Article  PubMed  Google Scholar 

  37. Miller, S. C., & Waite, C. Ephedrine-type alkaloid-containing dietary supplements and substance dependence. Psychosomatics 44:508–511, 2003.

    Article  PubMed  Google Scholar 

  38. Strain, E. C., & Griffiths, R. R. Caffeine-related disorders. In B. J. Sadock & V. A. Sadock (Eds.), Comprehensive Textbook of Psychiatry (8th ed.). Baltimore, MD: Lippincott, Williams & Wilkins, 2004, pp. 1201–1210.

    Google Scholar 

  39. Popovich, N. G. (Ed.). Other medical disorders. In R. R. Berardi, E. M. DeSimone II, G. D. Newton, et al. (Eds.), Handbook of Nonprescription Drugs (14th ed.). Washington, DC: American Pharmaceutical Association, 2004.

    Google Scholar 

  40. Traboulsi, A. S., Viswanathan, R., & Coplan, J. Suicide attempt after use of herbal diet pill. American Journal of Psychiatry 159:318–319, 2002.

    Article  PubMed  Google Scholar 

  41. Jacobs, K. M., & Hirsch, K. A. Psychiatric complications of ma-huang. Psychosomatics 41:58–62, 2000.

    PubMed  Google Scholar 

  42. Kernan, W. N., Viscoli, C. M., Brass, L. M., Broderick, J. P., Brott, T., Feldmann, E., Morgenstern, L. B., Wilterdink, J. L., & Horwitz, R. I. Phenylpropanolamine and the risk of hemorrhagic stroke. The New England Journal of Medicine 343:1826–1832, 2000.

    Article  PubMed  Google Scholar 

  43. Griffeths, P., & Gossap, M. A transcellular pattern of drug use: Khat. British Journal of Psychiatry 170:281–284, 1997.

    Article  Google Scholar 

  44. Gurley, B. J., Gardner, S. F., & Hubbard, M. A. Content versus label claims in ephedra-containing dietary supplements. American Journal of Health System Pharmacology 57:963–969, 2000.

    Google Scholar 

  45. Couper, F. J., Pemberton, M., Jarvis, A., Hughes, M., & Logan, B. K. Prevalence of drug use in commercial tractor-trailer drivers. Journal of Forensic Science 47:562–567, 2002.

    Google Scholar 

  46. Samenuk, D., Link, M. S., Homoud, M. K., Contreras, R., Theohardes, T. C., Wang, P. J., & Estes, N. A., III. Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine. May Clinical Proceedings 77:12–16, 2002.

    Article  Google Scholar 

  47. Blanck, H. M., Khan, L. K., & Serdula, M. K. Use of nonprescription weight loss products: Results from a multistate survey. The Journal of the American Medical Association 286:930–935, 2001.

    Article  Google Scholar 

  48. Goodhue, A., Bartel, R. L., & Smith, N. B. Exacerbation of psychosis by phenylpropanolamine. American Journal of Psychiatry 157:1021–1022, 2000.

    Article  PubMed  Google Scholar 

  49. Haller, C. A., & Benowitz, N. L. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. The New England Journal of Medicine 343:1833–1838, 2000.

    Article  PubMed  Google Scholar 

  50. Leikin, J. B., & Klein, L. Ephedra causes myocarditis. Journal of Toxicology Clinical Toxicology 38:353–354, 2000.

    PubMed  Google Scholar 

  51. Kurt, T. L. Hypersensitivity myocarditis with ephedra use (letter). Journal of Toxicology Clinical Toxicology 38:351, 2000.

    PubMed  Google Scholar 

  52. Snyder, P. J. Androgens. In J. G. Hardman, L. E. Limbird, & A. G. Gilman (Eds.), The Pharmacological Basis of Therapeutics (10th ed.). New York: McGraw-Hill Medical Publishers, 2001, pp. 1635–1648.

    Google Scholar 

  53. Kutscher, E. C., Lund, B. C., & Perry, P. J. Anabolic steroids: A review for the clinician. Sports Medicine 32:285–296, 2002.

    Article  PubMed  Google Scholar 

  54. Eisenberg, E. R., & Galloway, G. P. Anabolic-androgenic steroids. In J. H. Lowinson, P. Ruiz, R. B. Millman & J. G. Langrod (Eds.), Substance Abuse: A Comprehensive Textbook (4th ed.). Baltimore, MD: Williams & Wilkins, 2004, pp. 421–458.

    Google Scholar 

  55. Wichstrom, L., & Pedersen, W. Use of anabolic-androgenic steroids in adolescence: winning, looking good or being bad? Journal of Studies on Alcohol 62:5–13, 2001.

    PubMed  Google Scholar 

  56. Keane, H. Anabolic steroids and dependence. Contemporary Drug Problems 30:541–562, 2003.

    Google Scholar 

  57. Bardin, D. W. The anabolic action of testosterone. The New England Journal of Medicine 335:52–53, 1996.

    Article  PubMed  Google Scholar 

  58. Bhasin, S., Storer, T. W., Berman, N., Callegari, C., Clevenger, B., Phillips, J., Bunnell, T. J., Tricker, R., Shirazi, A., & Casaburi, R. The effects of supraphysiologic dose of testosterone on muscle size and strength in normal men. The New England Journal of Medicine 335:1–7, 1996.

    Article  PubMed  Google Scholar 

  59. Kanayama, G., Pope, H. G., Jr., Cohane, G., & Hudson, J. I. Risk factors for anabolic-androgenic steroid use among weightlifters: A case-control study. Drug and Alcohol Dependence 71:77–86, 2003.

    Article  PubMed  Google Scholar 

  60. Bolding, G., Sherr, L., & Elford, J. Use of anabolic steroids and associated health risks among gay men attending London gyms. Addiction 97:195–203, 2002.

    Article  PubMed  Google Scholar 

  61. Brower, K. J. Anabolic steroids: Potential for physical and psychological dependence. In C. E. Yesalis (Ed.), Anabolic Steroids in Sport and Exercise (2nd ed.). Champaign, IL: Human Kinetics, 2000, pp. 279–304, 287–288.

    Google Scholar 

  62. Kleinman, C. C., & Petit, C. E. Legal aspects of anabolic steroid use and abuse. In C. E. Yesalis (Ed.), Anabolic Steroids in Sport and Exercise (2nd ed.). Champaign, IL: Human Kinetics, 2000, pp. 333–359, 344.

    Google Scholar 

  63. Brower, K. J. Anabolic steroid abuse and dependence. Current Psychiatric Report 4:377–383, 2002.

    Google Scholar 

  64. Kanayama, G., Cohane, G., Weiss, R. D., & Pope, H. G., Jr. Past anabolic-androgenic steroid use among men admitted for stance abuse treatment: An underrecognized problem? Journal of Clinical Psychiatry 64:156–160, 2003.

    PubMed  Google Scholar 

  65. Johnston, L. D., O’Malley, P. M., Bachman, J. G., & Schulenberg, J. E. Monitoring the Future National Survey Results on Drug Use, 1975–2003. Vol. 1: Secondary School Students (NIH Publication No. 04-5507). Bethesda, MD: National Institute on Drug Abuse, 2003.

    Google Scholar 

  66. Pope, H. G., Jr., & Katz, D. L. Psychiatric effects of exogenous anabolic-androgenic steroids. In O. M. Wolkowitz & A. J. Rothschild (Eds.), Psychoneuroendocrinology for the Clinician. American Psychiatric Press, 2003, pp. 331–358.

    Google Scholar 

  67. Reeves, R. R., & Parker, J. D. Somatic dysfunction during carisoprodol cessation: Evidence for a carisoprodol withdrawal syndrome. Journal of the American Osteopathic Association 103:75–80, 2003.

    PubMed  Google Scholar 

  68. Bailey, D. N., & Briggs, J. R. Carisoprodol: An unrecognized drug of abuse. American Journal of Clinical Pathology 117:396–400, 2002.

    Article  PubMed  Google Scholar 

  69. Boyd, A. Bromocriptine and psychosis: A literature review. Psychiatric Quarterly 66:87–95, 1995.

    Article  PubMed  Google Scholar 

  70. American Psychiatric Association. The Diagnostic and Statistical Manual of Mental Disorders (4th ed., test revision). Washington, DC: American Psychiatric Press, 2000.

    Google Scholar 

  71. Schuckit, M. A., Tipp, J. E., Bucholz, K. K., Nurnberger, J. I., Jr., Hesselbrock, V. M., Crowe, R. R., & Kramer, J. The life-time rates of three major mood disorders and four major anxiety disorders in alcoholic and controls. Addiction 92:1289–1304, 1997.

    Article  PubMed  Google Scholar 

  72. Raimo, E. B., & Schuckit, M. A. Alcohol dependence and mood disorders. Addictive Behaviors 23:933–946, 1998.

    Article  PubMed  Google Scholar 

  73. Preuss, U. S., Schuckit, M. A., Smith, T. L., Danko, G. P., Dasher, A. C., Hesselbrock, M. N., Hesselbrock, V. M., & Nurnberger, J. I., Jr. A comparison of alcohol-induced and independent depression in alcoholics with histories of suicide attempts. Journal of Studies on Alcohol 63:498–502, 2002.

    PubMed  Google Scholar 

  74. Rush, A. J. Mood disorders: Treatment of depression. In B. J. Sadock & V. A. Sadock (Eds.), Comprehensive Textbook of Psychiatry (8th ed.). Philadelphia, PA: Lippincott, Williams & Wilkins, 2004, pp. 1652–1660.

    Google Scholar 

  75. Kane, J. M., & Marder, S. R. Schizophrenia: Somatic treatment. In B. J. Sadock & V. A. Sadock (Eds.), Comprehensive Textbook of Psychiatry (8th ed.). Philadelphia, PA: Lippincott, Williams & Wilkins, 2004, pp. 1467–1475.

    Google Scholar 

  76. Frauger, E., Thirion, X., Chanut, C., Natali, F., Debruyne, D., Saillard, C., Pradel, V., Reggio, P., & Micallef, J. Misuse of trihexyphenidyl (Artane, Parkinane): Recent trends (Article in French). Therapie 58:541–547, 2003.

    Article  PubMed  Google Scholar 

  77. Buhrich, N., Weller, A., & Kevans, P. Misuse of anticholinergic drugs by people with serious mental illness. Psychiatric Services 51:928–929, 2000.

    Article  PubMed  Google Scholar 

  78. Hirose, S. Insomnia related to biperiden withdrawal in two schizophrenic patients. International Clinical Psychopharmacology 15:357–359, 2000.

    Article  PubMed  Google Scholar 

  79. Brown, J. H., & Taylor, P. Muscarinic receptor agonists and antagonists. In J. G. Hardman, L. E. Limbird & A. G. Gilman (Eds.), The Pharmacological Basis of Therapeutics (10th ed.). New York: McGraw-Hill Medical Publishers, 2001, pp. 155–174.

    Google Scholar 

  80. Nemeroff, C. B., & Putnam, J. S. Anticholinergics and amantadine. In B. J. Sadock & V. A. Sadock (Eds.), Comprehensive Textbook of Psychiatry (8th ed.). Philadelphia, PA: Lippincott, Williams & Wilkins, pp. 2727–2731, 2004.

    Google Scholar 

  81. Halpern, J. H. Hallucinogens and dissociative agents naturally growing in the United States. Pharmacology & Therapeutics 102:131–138, 2004.

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

(2006). Over-the-Counter (OTC) Drugs and Some Prescription Drugs. In: Drug and Alcohol Abuse. Springer, Boston, MA. https://doi.org/10.1007/0-387-25733-0_10

Download citation

Publish with us

Policies and ethics

Search

Navigation